AI assistant
CONMED Corp — Director's Dealing 2017
Nov 7, 2017
31971_dirs_2017-11-07_e7bcd8b9-5266-45d8-8b09-6e2a3406c69d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2017-11-03
Reporting Person: POMILIO LUKE A (EVP, Finance & CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-11-03 | Common Stock | M | 10020 | $39.87 | Acquired | 44472 | Direct |
| 2017-11-03 | Common Stock | S | 10020 | $53.57 | Disposed | 34452 | Direct |
| 2017-11-03 | Common Stock | M | 8000 | $16.46 | Acquired | 42452 | Direct |
| 2017-11-03 | Common Stock | F | 5277 | $53.37 | Disposed | 37175 | Direct |
| 2017-11-03 | Common Stock | M | 10000 | $19.26 | Acquired | 47175 | Direct |
| 2017-11-03 | Common Stock | F | 6854 | $53.37 | Disposed | 40321 | Direct |
| 2017-11-03 | Common Stock | M | 10000 | $27.63 | Acquired | 50321 | Direct |
| 2017-11-03 | Common Stock | F | 7626 | $53.37 | Disposed | 42695 | Direct |
| 2017-11-03 | Common Stock | M | 10000 | $26.09 | Acquired | 52695 | Direct |
| 2017-11-03 | Common Stock | F | 7484 | $53.37 | Disposed | 45211 | Direct |
| 2017-11-03 | Common Stock | M | 9600 | $32.93 | Acquired | 54811 | Direct |
| 2017-11-03 | Common Stock | F | 7790 | $53.37 | Disposed | 47021 | Direct |
| 2017-11-03 | Common Stock | M | 4680 | $44.90 | Acquired | 51701 | Direct |
| 2017-11-03 | Common Stock | F | 4315 | $53.37 | Disposed | 47386 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-11-03 | Options To Purchase Common Stock | $39.87 | M | 10020 | Disposed | 2026-03-01 | Common Stock (10020) | Direct |
| 2017-11-03 | Sars (Stock Appreciation Rights) | $16.46 | M | 8000 | Disposed | 2019-06-01 | Common Stock (8000) | Direct |
| 2017-11-03 | Sars (Stock Appreciation Rights) | $19.26 | M | 10000 | Disposed | 2020-06-01 | Common Stock (10000) | Direct |
| 2017-11-03 | Sars (Stock Appreciation Rights) | $27.63 | M | 10000 | Disposed | 2021-06-01 | Common Stock (10000) | Direct |
| 2017-11-03 | Sars (Stock Appreciation Rights) | $26.09 | M | 10000 | Disposed | 2022-06-01 | Common Stock (10000) | Direct |
| 2017-11-03 | Sars (Stock Appreciation Rights) | $32.93 | M | 9600 | Disposed | 2023-06-01 | Common Stock (9600) | Direct |
| 2017-11-03 | Sars (Stock Appreciation Rights) | $44.90 | M | 4680 | Disposed | 2024-06-01 | Common Stock (4680) | Direct |
Footnotes
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.55 to $53.595. Full information regarding the number of shares sold at each separate price will be provided upon request of the commission staff, ConMed, or a ConMed security holder."
F2: The incentive stock options ("ISOs") were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period
F3: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.